education
|
points
Download App
Hong Kong
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Points
Download App
Country
Hong Kong
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Advertisement
Advertisement
MIMS home
Drugs
Info
Refero
Refero
rifaximin
Manufacturer:
Alfa Wassermann
Distributor:
Chong Lap
SELECT
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Caution For Usage
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Caution For Usage
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Rifaximin
Indications/Uses
Decrease recurrence of overt hepatic encephalopathy episodes in patients ≥18 yr.
Click to view Refero detailed prescribing information
Dosage/Direction for Use
Recommended dose: 550 mg bd.
Click to view Refero detailed prescribing information
Overdosage
View
Refero overdosage
for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity; intestinal obstruction.
Click to view Refero detailed prescribing information
Special Precautions
Clostridium difficile
associated diarrhoea. Concomitant administration w/ other rifamycins. Reddish discoloration of the urine. Severe hepatic impairment. Concomitant use w/ a P-glycoprotein inhibitor. Pregnancy & lactation. Childn.
Click to view Refero detailed prescribing information
Use In Pregnancy & Lactation
Click to view Refero detailed prescribing information
Adverse Reactions
Depression; dizziness, headache; dyspnoea; abdominal pain upper, abdominal distension, diarrhoea, nausea, vomiting, ascites; rashes, pruritus; muscle spasms, arthralgia; oedema peripheral.
Click to view Refero detailed prescribing information
Drug Interactions
Possible decreased exposure of CYP3A4 substrates (eg, warfarin, antiepileptics, antiarrhythmics, OCs) in hepatic impaired patients. Increased systemic exposure w/ ciclosporin (potent P-glycoprotein inibitor).
Click to view Refero detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine...
Click to view Refero detailed prescribing information
Storage
View
Refero storage
conditions for details to ensure optimal shelf-life.
Description
View
Refero description
for details of the chemical structure and excipients (inactive components).
Action
View
Refero mechanism of action
for pharmacodynamics and pharmacokinetics details.
MIMS Class
Other Antibiotics
ATC Classification
A07AA11 - rifaximin ; Belongs to the class of antibiotics. Used in the treatment of intestinal infections.
Regulatory Classification
A
Presentation/Packing
Form
Refero FC tab 550 mg
Packing/Price
56's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in